Our Offerings
By Industry By Function
About Us
Our Viewpoint
NEW
 Senior Management Experts Panel Global Consultants Press Releases Blog
Infographics Market Insights Case Studies Illustrations In The Press
Contact Us
The Business Research Company Logo
Reports Store
Top 50 Healthcare Market Reports
NEW
 Top 50 Non-Healthcare Market Reports
NEW
 Opportunities And Strategies Reports Aerospace And Defense Agriculture Chemicals Construction
Electrical And Electronics Financial Services Food And Beverages Healthcare Services Hospitality Information Technology Machinery Media
Medical Equipment Metal And Mineral Mining Oil And Gas Paper, Plastics, Rubber, Wood And Textile Pharmaceuticals Professional Services Recreation
Retail And Wholesale Services Social Services Transport Transport Services Utilities Veterinary Healthcare Filter Reports by Trends
NEW
Market Intelligence Platform
About GMM Global Forecast
NEW
 Mega Trends Analysis
Consultancies Corporate Planning & Strategy Academic Financial Services Legal Services
Pricing Methodology Sources FAQ Press Coverage
Customized Research
Find Customers Optimise Your Marketing Mix Evaluate Competitors Identify Market Opportunities Develop Products And Services
Distributor And Partner Research Plan Finances Streamline Your Operations Devise Market Entry Strategy Explore Custom Research Packages
NEW
Continuous Research
Desk Research Research Reports Senior Executive Interviews Consumer Research Market Sizing And Forecasts
Company Information Analytics And Data Visualization Research Automation Web Crawling And Spidering AI-Empowered Research Services
Request Proposal
Anticonvulsants Global Market Report 2025
Download Free Sample Buy Now
Global Anticonvulsants Market Report 2025

Report Price : $4490.00

Pages :

Format : PDF

Published : December 2025

Delivery Time : 2-3 Business Days

Purchase This Report Download Sample PDF
Purchase This Report

Anticonvulsants Global Market Report 2025

By Type (Pyrimidinediones, Benzodiazepines, Fructose Derivatives, Aromatic Allylic Alcohols, Valproylamides, Carboxamides, Bromides, Other Types), By Drug Generation (First Generation, Second Generation, Third Generation), By Dosage (Capsule, Tablet, Cream, Liquid, Rectal Gel, Other Dosages), By Application (Migraine, Epilepsy, Neuropathic Pain, Anxiety, Fibromyalgia, Bipolar Disorder, Borderline Personality Disorder), By End-User (Hospitals, Clinics, Other End-Users) – Impact of Tariff and Trade War on Market Size, Growth, Trends, and Forecast 2025–2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Anticonvulsants Market Overview

• Anticonvulsants market size has reached to $18.85 billion in 2024

• Expected to grow to $22.29 billion in 2029 at a compound annual growth rate (CAGR) of 3.7%

• Growth Driver: The Surge In Epilepsy Cases Drives Growth In The Anticonvulsants Market

• Market Trend: Innovative Product Development Drives Advancements In The Anticonvulsants Market

• North America was the largest region in 2024 and Asia-Pacific is the fastest growing region.

What Is Covered Under Anticonvulsants Market?

Anticonvulsants, also called anti-seizure medication and antiepileptics, refer to a type of drug or medication used to prevent and treat seizures or convulsions by controlling abnormal electrical activity in the brain. This medication is used to treat conditions such as nerve pain and restless leg syndrome.

The main types of anticonvulsants include pyrimidinediones, fructose derivatives, aromatic allylic alcohols, valproylamides, carboxamides, bromides and others. Pyrimidine refers to a heterocyclic aromatic organic compound that serves as a component of nucleic acids (such as DNA and RNA), certain proteins, starches, and others. These drugs are generated by the first-generation, second generation and third-generations and consumed in dosage forms of capsules, tablets, liquids, rectal gel and others for applications in migraine, epilepsy, neuropathic pain, anxiety, fibromyalgia, bipolar disorder, borderline personality disorder. These are used in various end-user industries such as hospitals, clinics and others.

Anticonvulsants Market Size and growth rate 2025 to 2029: Graph

What Is The Anticonvulsants Market Size 2025 And Growth Rate?

The anticonvulsants market size has grown steadily in recent years. It will grow from$18.85 billion in 2024 to $19.25 billion in 2025 at a compound annual growth rate (CAGR) of 2.1%. The growth in the historic period can be attributed to the rising prevalence of epilepsy, advancements in diagnostic capabilities, expanding indications, focus on personalized medicine, and increased awareness and education

What Is The Anticonvulsants Market Growth Forecast?

The anticonvulsants market size is expected to see steady growth in the next few years. It will grow to $22.29 billion in 2029 at a compound annual growth rate (CAGR) of 3.7%. The growth in the forecast period can be attributed to continuing increase in epilepsy cases, expanding applications in neuropsychiatry, development of new anticonvulsant agents, increasing emphasis on mental health, global health initiatives. Major trends in the forecast period include pediatric applications and formulations, shift towards extended-release formulations, growing adoption of generic versions, integration with digital health solutions, and research on neuroprotective effects.

The forecast of 3.7% growth over the next five years reflects a modest reduction of 0.2% from the previous estimate for this market. This reduction is primarily due to the impact of tariffs between the US and other countries. The imposition of tariffs may pose a significant challenge for epilepsy centers by increasing costs of second-generation seizure medications like levetiracetam imported from Israel and Ireland, potentially reducing treatment options and raising neurology care expenditures. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us

What’s The Trade War Impact On Pharmaceuticals Industry?

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the pharmaceutical companies contend with tariffs on APIs, glass vials, and lab equipment inputs with few alternative sources. Generic drug makers, operating on razor-thin margins, are especially vulnerable, with some reducing production of low-profit medicines. Biotech firms face delays in clinical trials due to tariff-related shortages of specialized reagents. In response, the industry is expanding API production in India and Europe, increasing inventory stockpiles, and pushing for trade exemptions for essential medicines.

How Is The Anticonvulsants Market Segmented?

1) By Type: Pyrimidinediones, Benzodiazepines, Fructose Derivatives, Aromatic Allylic Alcohols, Valproylamides, Carboxamides, Bromides, Other Types

2) By Drug Generation: First Generation, Second Generation, Third Generation

3) By Dosage: Capsule, Tablet, Cream, Liquid, Rectal Gel, Other Dosages

4) By Application: Migraine, Epilepsy, Neuropathic Pain, Anxiety, Fibromyalgia, Bipolar Disorder, Borderline Personality Disorder

5) By End-User: Hospitals, Clinics, Other End-Users

Subsegments:

1) By Pyrimidinediones: Stiripentol

2) By Benzodiazepines: Clonazepam, Diazepam, Lorazepam

3) By Fructose Derivatives: S-licarbazepine, Other Fructose Derivatives

4) By Aromatic Allylic Alcohols: Felbamate, Other Aromatic Allylic Alcohols

5) By Valproylamides: Valproic Acid, Divalproex Sodium

6) By Carboxamides: Lamotrigine, Other Carboxamides

7) By Bromides: Potassium Bromide, Sodium Bromide

8) By Other Types: Topiramate, Zonisamide, Ethosuximide

What Is Driving The Anticonvulsants Market? The Surge In Epilepsy Cases Drives Growth In The Anticonvulsants Market

The rise in the prevalence of epilepsy is expected to propel the growth of the anticonvulsants market going forward. Epilepsy is a common disorder that affects the brain and frequently results in seizures. It is a chronic nontransmissible disease of the brain that affects people of all ages. Anticonvulsants are medications used to suppress seizures in people with epilepsy. Anticonvulsants help control symptoms of epilepsy by blocking the abnormal electrical activity in the brain that causes seizures and is not necessarily a cure for the disease. For instance, in February 2023, according to the World Health Organization, a Switzerland-based United Nations agency responsible for public health, globally, an estimated 5 million people are diagnosed with epilepsy yearly. The high-income countries have an estimated 49 per 0.1 million people are diagnosed with epilepsy each year, and as many as 139 per 0.1 million in low- and middle-income countries. Therefore, the rise in the prevalence of epilepsy is driving the growth of the anticonvulsants industry going forward.

What Is Driving The Anticonvulsants Market? The Growing Geriatric Population Fuels Expansion Of The Anticonvulsant Market

The growing geriatric population is expected to propel the growth of the anticonvulsant market going forward. The geriatric population refers to the demographic segment comprising elderly individuals. While the specific age threshold for defining the geriatric population may vary across different contexts and countries, it generally encompasses people aged 65 and older. Anticonvulsants play an important role in the geriatric population, particularly in the management of seizures and epilepsy, which are common conditions in elderly patients. For instance, in October 2022, according to the World Health Organization, a Switzerland-based specialized agency of the United Nations responsible for international public health, 1 in 6 people in the world will be aged 60 years or older by 2030. At this point, there will be 1.4 billion people, up from 1 billion in 2020, who are 60 years of age or older. The number of individuals 60 and older in the world will double (to 2.1 billion) by the year 2050. Between 2020 and 2050, there will be 426 million more people who are 80 years of age or older than there are today. Therefore, the growing geriatric population is driving the growth of the anticonvulsant industry.

Who Are The Major Players In The Global Anticonvulsants Market?

Major companies operating in the anticonvulsants market include Eisai Co Ltd., GlaxoSmithKline plc, Pfizer Inc., Johnson & Johnson Services Inc., Novartis AG, Jazz Pharmaceuticals Inc., UCB SA, Teva Pharmaceutical Industries Ltd., Sunovion Pharmaceuticals Inc., Sanofi SA, Zydus Lifesciences Ltd., Lupin Limited, Ratiopharm Group, Kannalife Inc., AbbVie Inc., Sun Pharmaceutical Industries Ltd., Cipla Limited, Mylan N.V., Aurobindo Pharma Limited, Dr. Reddy's Laboratories Ltd., Torrent Pharmaceuticals Ltd., Hikma Pharmaceuticals plc, AstraZeneca plc, Glenmark Pharmaceuticals Limited, Laurus Labs Limited, Biocon Limited, Recordati S.p.A., Neurocrine Biosciences Inc.

What Are The Key Trends Of The Global Anticonvulsants Market? Innovative Product Development Drives Advancements In The Anticonvulsants Market

Product development is a key trend gaining popularity in the anticonvulsants market. Major companies operating in the anticonvulsants market are focused on developing innovative products to strengthen their position and gain a competitive advantage. For instance, in December 2022, Lupin Limited, an India-based pharmaceutical company, launched an abbreviated new drug application, Rufinamide tablets USP, 200 mg and 400 mg, an anticonvulsant drug. Rufinamide is used with other medications to control seizures in people who have a severe form of epilepsy called Lennox-Gastaut syndrome, which begins during childhood and causes several types of seizures, behavioral disturbances, and developmental delays in an individual.

What Are The Key Trends Of The Global Anticonvulsants Market? Advancements In Anticonvulsants Market Fueled By Approval Of Novel Therapies For Seizure Disorders

Major companies operating in the anticonvulsants market are focused on introducing advanced drug solutions and getting them approved by national government agencies to gain a competitive edge in the market. The introduction and approval of novel drug solutions aim to significantly impact the availability of advanced therapies for patients with seizures associated with various syndromes. For instance, in March 2022, UCB, a Belgium-based biopharmaceutical company, announced the U.S. Food and Drug Administration (FDA) approval of FINTEPLA (fenfluramine) oral solution CIV for the treatment of seizures associated with Lennox-Gastaut syndrome in patients two years of age and older. Fenfluramine has been effective in treating the most challenging types of seizures, such as drop seizures, in which the patient experiences a sudden loss of muscular tone, a limp state, and a significant risk of falling and becoming hurt. Current antiseizure regimens can be continued with fenfluramine, as it operates through a distinct mechanism that is both complementary and different from existing epileptic drugs. Patients with LGS showed statistically significant improvements on the Clinical Global Impression Scale (CG-I) when using fenfluramine in the global placebo-controlled phase 3 clinical trial.

Need data on a specific region in this market?
Request Regional Data

Anticonvulsants Market Merger And Acquisition: Catalyst Pharmaceuticals Completes the Acquisition of U.S. Rights to FYCOMPA (Perampanel) CIII

In January 2023, Catalyst Pharmaceuticals, a US-based commercial-stage biopharmaceutical company, acquired U.S. rights of FYCOMPA (Perampanel) CIII from Eisai Co. Ltd for an undisclosed amount. This acquisition FYCOMPA (perampanel) aims to strategically enhance the company's portfolio in the neurology sector, particularly focusing on epilepsy treatment. FYCOMPA (perampanel) CIII is a prescription medication used for the treatment of epilepsy, specifically indicated for partial-onset seizures. Eisai Co. Ltd is a Japan-based pharmaceutical company manufactures anticonvulsant drugs.

Regional Analysis For The Global Anticonvulsants Market

North America was the largest region in the anticonvulsants market in 2024.Asia-Pacific is expected to be the fastest-growing region in the global anticonvulsants market report during the forecast period. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Anticonvulsants Market?

The anticonvulsant market consists of sales of drugs such as phenobarbital, phenytoin, carbamazepine, levetiracetam, ethosuximide, clonazepam, diazepam, lorazepam, and midazolam. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Anticonvulsants Industry?

The anticonvulsants market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the anticonvulsants industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Anticonvulsants Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2025 $19.25 billion
Revenue Forecast In 2034 $22.29 billion
Growth Rate CAGR of 3.7% from 2025 to 2034
Base Year For Estimation 2024
Actual Estimates/Historical Data 2019-2024
Forecast Period 2025 - 2029 - 2034
Market Representation Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered 1) By Type: Pyrimidinediones, Benzodiazepines, Fructose Derivatives, Aromatic Allylic Alcohols, Valproylamides, Carboxamides, Bromides, Other Types
2) By Drug Generation: First Generation, Second Generation, Third Generation
3) By Dosage: Capsule, Tablet, Cream, Liquid, Rectal Gel, Other Dosages
4) By Application: Migraine, Epilepsy, Neuropathic Pain, Anxiety, Fibromyalgia, Bipolar Disorder, Borderline Personality Disorder
5) By End-User: Hospitals, Clinics, Other End-Users Subsegments: 1) By Pyrimidinediones: Stiripentol
2) By Benzodiazepines: Clonazepam, Diazepam, Lorazepam
3) By Fructose Derivatives: S-licarbazepine, Other Fructose Derivatives
4) By Aromatic Allylic Alcohols: Felbamate, Other Aromatic Allylic Alcohols
5) By Valproylamides: Valproic Acid, Divalproex Sodium 6) By Carboxamides: Lamotrigine, Other Carboxamides 7) By Bromides: Potassium Bromide, Sodium Bromide 8) By Other Types: Topiramate, Zonisamide, Ethosuximide
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled Eisai Co Ltd., GlaxoSmithKline plc, Pfizer Inc., Johnson & Johnson Services Inc ., Novartis AG, Jazz Pharmaceuticals Inc., UCB SA, Teva Pharmaceutical Industries Ltd., Sunovion Pharmaceuticals Inc., Sanofi SA, Zydus Lifesciences Ltd., Lupin Limited, Ratiopharm Group, Kannalife Inc., AbbVie Inc., Sun Pharmaceutical Industries Ltd., Cipla Limited, Mylan N.V., Aurobindo Pharma Limited, Dr. Reddy's Laboratories Ltd., Torrent Pharmaceuticals Ltd., Hikma Pharmaceuticals plc, AstraZeneca plc, Glenmark Pharmaceuticals Limited, Laurus Labs Limited, Biocon Limited, Recordati S.p.A., Neurocrine Biosciences Inc.
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

2. Anticonvulsants Market Characteristics

3. Anticonvulsants Market Trends And Strategies

4. Anticonvulsants Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Anticonvulsants Growth Analysis And Strategic Analysis Framework

5.1. Global Anticonvulsants PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Anticonvulsants Market Growth Rate Analysis

5.4. Global Anticonvulsants Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Anticonvulsants Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Anticonvulsants Total Addressable Market (TAM)

6. Anticonvulsants Market Segmentation

6.1. Global Anticonvulsants Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Pyrimidinediones

Benzodiazepines

Fructose Derivatives

Aromatic Allylic Alcohols

Valproylamides

Carboxamides

Bromides

Other Types

6.2. Global Anticonvulsants Market, Segmentation By Drug Generation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

First Generation

Second Generation

Third Generation

6.3. Global Anticonvulsants Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Capsule

Tablet

Cream

Liquid

Rectal Gel

Other Dosages

6.4. Global Anticonvulsants Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Migraine

Epilepsy

Neuropathic Pain

Anxiety

Fibromyalgia

Bipolar Disorder

Borderline Personality Disorder

6.5. Global Anticonvulsants Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hospitals

Clinics

Other End-Users

6.6. Global Anticonvulsants Market, Sub-Segmentation Of Pyrimidinediones, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Stiripentol

6.7. Global Anticonvulsants Market, Sub-Segmentation Of Benzodiazepines, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Clonazepam

Diazepam

Lorazepam

6.8. Global Anticonvulsants Market, Sub-Segmentation Of Fructose Derivatives, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

S-licarbazepine

Other Fructose Derivatives

6.9. Global Anticonvulsants Market, Sub-Segmentation Of Aromatic Allylic Alcohols, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Felbamate

Other Aromatic Allylic Alcohols

6.10. Global Anticonvulsants Market, Sub-Segmentation Of Valproylamides, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Valproic Acid

Divalproex Sodium

6.11. Global Anticonvulsants Market, Sub-Segmentation Of Carboxamides, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Lamotrigine

Other Carboxamides

6.12. Global Anticonvulsants Market, Sub-Segmentation Of Bromides, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Potassium Bromide

Sodium Bromide

6.13. Global Anticonvulsants Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Topiramate

Zonisamide

Ethosuximide

7. Anticonvulsants Market Regional And Country Analysis

7.1. Global Anticonvulsants Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Anticonvulsants Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Anticonvulsants Market

8.1. Asia-Pacific Anticonvulsants Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Anticonvulsants Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Anticonvulsants Market, Segmentation By Drug Generation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Anticonvulsants Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Anticonvulsants Market

9.1. China Anticonvulsants Market Overview

9.2. China Anticonvulsants Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Anticonvulsants Market, Segmentation By Drug Generation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Anticonvulsants Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Anticonvulsants Market

10.1. India Anticonvulsants Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Anticonvulsants Market, Segmentation By Drug Generation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Anticonvulsants Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Anticonvulsants Market

11.1. Japan Anticonvulsants Market Overview

11.2. Japan Anticonvulsants Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Anticonvulsants Market, Segmentation By Drug Generation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Anticonvulsants Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Anticonvulsants Market

12.1. Australia Anticonvulsants Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Anticonvulsants Market, Segmentation By Drug Generation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Anticonvulsants Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Anticonvulsants Market

13.1. Indonesia Anticonvulsants Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Anticonvulsants Market, Segmentation By Drug Generation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Anticonvulsants Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Anticonvulsants Market

14.1. South Korea Anticonvulsants Market Overview

14.2. South Korea Anticonvulsants Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Anticonvulsants Market, Segmentation By Drug Generation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Anticonvulsants Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Anticonvulsants Market

15.1. Western Europe Anticonvulsants Market Overview

15.2. Western Europe Anticonvulsants Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Anticonvulsants Market, Segmentation By Drug Generation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Anticonvulsants Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Anticonvulsants Market

16.1. UK Anticonvulsants Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Anticonvulsants Market, Segmentation By Drug Generation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Anticonvulsants Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Anticonvulsants Market

17.1. Germany Anticonvulsants Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Anticonvulsants Market, Segmentation By Drug Generation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Anticonvulsants Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Anticonvulsants Market

18.1. France Anticonvulsants Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Anticonvulsants Market, Segmentation By Drug Generation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Anticonvulsants Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Anticonvulsants Market

19.1. Italy Anticonvulsants Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Anticonvulsants Market, Segmentation By Drug Generation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Anticonvulsants Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Anticonvulsants Market

20.1. Spain Anticonvulsants Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Anticonvulsants Market, Segmentation By Drug Generation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Anticonvulsants Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Anticonvulsants Market

21.1. Eastern Europe Anticonvulsants Market Overview

21.2. Eastern Europe Anticonvulsants Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Anticonvulsants Market, Segmentation By Drug Generation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Anticonvulsants Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Anticonvulsants Market

22.1. Russia Anticonvulsants Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Anticonvulsants Market, Segmentation By Drug Generation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Anticonvulsants Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Anticonvulsants Market

23.1. North America Anticonvulsants Market Overview

23.2. North America Anticonvulsants Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Anticonvulsants Market, Segmentation By Drug Generation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Anticonvulsants Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Anticonvulsants Market

24.1. USA Anticonvulsants Market Overview

24.2. USA Anticonvulsants Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Anticonvulsants Market, Segmentation By Drug Generation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Anticonvulsants Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Anticonvulsants Market

25.1. Canada Anticonvulsants Market Overview

25.2. Canada Anticonvulsants Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Anticonvulsants Market, Segmentation By Drug Generation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Anticonvulsants Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Anticonvulsants Market

26.1. South America Anticonvulsants Market Overview

26.2. South America Anticonvulsants Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Anticonvulsants Market, Segmentation By Drug Generation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Anticonvulsants Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Anticonvulsants Market

27.1. Brazil Anticonvulsants Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Anticonvulsants Market, Segmentation By Drug Generation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Anticonvulsants Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Anticonvulsants Market

28.1. Middle East Anticonvulsants Market Overview

28.2. Middle East Anticonvulsants Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Anticonvulsants Market, Segmentation By Drug Generation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Anticonvulsants Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Anticonvulsants Market

29.1. Africa Anticonvulsants Market Overview

29.2. Africa Anticonvulsants Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Anticonvulsants Market, Segmentation By Drug Generation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Anticonvulsants Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Anticonvulsants Market Competitive Landscape And Company Profiles

30.1. Anticonvulsants Market Competitive Landscape

30.2. Anticonvulsants Market Company Profiles

30.2.1. Eisai Co Ltd. Overview, Products and Services, Strategy and Financial Analysis

30.2.2. GlaxoSmithKline plc Overview, Products and Services, Strategy and Financial Analysis

30.2.3. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.4. Johnson & Johnson Services Inc . Overview, Products and Services, Strategy and Financial Analysis

30.2.5. Novartis AG Overview, Products and Services, Strategy and Financial Analysis

31. Anticonvulsants Market Other Major And Innovative Companies

31.1. Jazz Pharmaceuticals Inc.

31.2. UCB SA

31.3. Teva Pharmaceutical Industries Ltd.

31.4. Sunovion Pharmaceuticals Inc.

31.5. Sanofi SA

31.6. Zydus Lifesciences Ltd.

31.7. Lupin Limited

31.8. Ratiopharm Group

31.9. Kannalife Inc.

31.10. AbbVie Inc.

31.11. Sun Pharmaceutical Industries Ltd.

31.12. Cipla Limited

31.13. Mylan N.V.

31.14. Aurobindo Pharma Limited

31.15. Dr. Reddy's Laboratories Ltd.

32. Global Anticonvulsants Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Anticonvulsants Market

34. Recent Developments In The Anticonvulsants Market

35. Anticonvulsants Market High Potential Countries, Segments and Strategies

35.1 Anticonvulsants Market In 2029 - Countries Offering Most New Opportunities

35.2 Anticonvulsants Market In 2029 - Segments Offering Most New Opportunities

35.3 Anticonvulsants Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Table 3: Global Anticonvulsants Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 4: Global Anticonvulsants Market, Segmentation By Drug Generation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 5: Global Anticonvulsants Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 6: Global Anticonvulsants Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 7: Global Anticonvulsants Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 8: Global Anticonvulsants Market, Sub-Segmentation Of Pyrimidinediones, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 9: Global Anticonvulsants Market, Sub-Segmentation Of Benzodiazepines, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 10: Global Anticonvulsants Market, Sub-Segmentation Of Fructose Derivatives, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 11: Global Anticonvulsants Market, Sub-Segmentation Of Aromatic Allylic Alcohols, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 12: Global Anticonvulsants Market, Sub-Segmentation Of Valproylamides, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 13: Global Anticonvulsants Market, Sub-Segmentation Of Carboxamides, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 14: Global Anticonvulsants Market, Sub-Segmentation Of Bromides, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 15: Global Anticonvulsants Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 16: Global Anticonvulsants Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 17: Global Anticonvulsants Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 18: Asia-Pacific, Anticonvulsants Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 19: Asia-Pacific, Anticonvulsants Market, Segmentation By Drug Generation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 20: Asia-Pacific, Anticonvulsants Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 21: China, Anticonvulsants Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 22: China, Anticonvulsants Market, Segmentation By Drug Generation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 23: China, Anticonvulsants Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 24: India, Anticonvulsants Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 25: India, Anticonvulsants Market, Segmentation By Drug Generation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 26: India, Anticonvulsants Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 27: Japan, Anticonvulsants Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 28: Japan, Anticonvulsants Market, Segmentation By Drug Generation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 29: Japan, Anticonvulsants Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 30: Australia, Anticonvulsants Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 31: Australia, Anticonvulsants Market, Segmentation By Drug Generation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 32: Australia, Anticonvulsants Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 33: Indonesia, Anticonvulsants Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 34: Indonesia, Anticonvulsants Market, Segmentation By Drug Generation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 35: Indonesia, Anticonvulsants Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 36: South Korea, Anticonvulsants Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 37: South Korea, Anticonvulsants Market, Segmentation By Drug Generation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 38: South Korea, Anticonvulsants Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 39: Western Europe, Anticonvulsants Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 40: Western Europe, Anticonvulsants Market, Segmentation By Drug Generation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 41: Western Europe, Anticonvulsants Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 42: UK, Anticonvulsants Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 43: UK, Anticonvulsants Market, Segmentation By Drug Generation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 44: UK, Anticonvulsants Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 45: Germany, Anticonvulsants Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 46: Germany, Anticonvulsants Market, Segmentation By Drug Generation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 47: Germany, Anticonvulsants Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 48: France, Anticonvulsants Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 49: France, Anticonvulsants Market, Segmentation By Drug Generation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 50: France, Anticonvulsants Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 51: Italy, Anticonvulsants Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 52: Italy, Anticonvulsants Market, Segmentation By Drug Generation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 53: Italy, Anticonvulsants Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 54: Spain, Anticonvulsants Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 55: Spain, Anticonvulsants Market, Segmentation By Drug Generation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 56: Spain, Anticonvulsants Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 57: Eastern Europe, Anticonvulsants Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 58: Eastern Europe, Anticonvulsants Market, Segmentation By Drug Generation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 59: Eastern Europe, Anticonvulsants Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 60: Russia, Anticonvulsants Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 61: Russia, Anticonvulsants Market, Segmentation By Drug Generation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 62: Russia, Anticonvulsants Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 63: North America, Anticonvulsants Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 64: North America, Anticonvulsants Market, Segmentation By Drug Generation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 65: North America, Anticonvulsants Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 66: USA, Anticonvulsants Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 67: USA, Anticonvulsants Market, Segmentation By Drug Generation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 68: USA, Anticonvulsants Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 69: Canada, Anticonvulsants Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 70: Canada, Anticonvulsants Market, Segmentation By Drug Generation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 71: Canada, Anticonvulsants Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 72: South America, Anticonvulsants Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 73: South America, Anticonvulsants Market, Segmentation By Drug Generation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 74: South America, Anticonvulsants Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 75: Brazil, Anticonvulsants Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 76: Brazil, Anticonvulsants Market, Segmentation By Drug Generation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 77: Brazil, Anticonvulsants Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 78: Middle East, Anticonvulsants Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 79: Middle East, Anticonvulsants Market, Segmentation By Drug Generation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 80: Middle East, Anticonvulsants Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 81: Africa, Anticonvulsants Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 82: Africa, Anticonvulsants Market, Segmentation By Drug Generation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 83: Africa, Anticonvulsants Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 84: Eisai Co Ltd. Financial Performance
  • Table 85: GlaxoSmithKline plc Financial Performance
  • Table 86: Pfizer Inc. Financial Performance
  • Table 87: Johnson & Johnson Services Inc . Financial Performance
  • Table 88: Novartis AG Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Figure 3: Global Anticonvulsants Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 4: Global Anticonvulsants Market, Segmentation By Drug Generation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 5: Global Anticonvulsants Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 6: Global Anticonvulsants Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 7: Global Anticonvulsants Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 8: Global Anticonvulsants Market, Sub-Segmentation Of Pyrimidinediones, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 9: Global Anticonvulsants Market, Sub-Segmentation Of Benzodiazepines, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 10: Global Anticonvulsants Market, Sub-Segmentation Of Fructose Derivatives, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 11: Global Anticonvulsants Market, Sub-Segmentation Of Aromatic Allylic Alcohols, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 12: Global Anticonvulsants Market, Sub-Segmentation Of Valproylamides, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 13: Global Anticonvulsants Market, Sub-Segmentation Of Carboxamides, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 14: Global Anticonvulsants Market, Sub-Segmentation Of Bromides, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 15: Global Anticonvulsants Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 16: Global Anticonvulsants Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 17: Global Anticonvulsants Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 18: Asia-Pacific, Anticonvulsants Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 19: Asia-Pacific, Anticonvulsants Market, Segmentation By Drug Generation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 20: Asia-Pacific, Anticonvulsants Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 21: China, Anticonvulsants Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 22: China, Anticonvulsants Market, Segmentation By Drug Generation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 23: China, Anticonvulsants Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 24: India, Anticonvulsants Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 25: India, Anticonvulsants Market, Segmentation By Drug Generation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 26: India, Anticonvulsants Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 27: Japan, Anticonvulsants Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 28: Japan, Anticonvulsants Market, Segmentation By Drug Generation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 29: Japan, Anticonvulsants Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 30: Australia, Anticonvulsants Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 31: Australia, Anticonvulsants Market, Segmentation By Drug Generation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 32: Australia, Anticonvulsants Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 33: Indonesia, Anticonvulsants Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 34: Indonesia, Anticonvulsants Market, Segmentation By Drug Generation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 35: Indonesia, Anticonvulsants Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 36: South Korea, Anticonvulsants Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 37: South Korea, Anticonvulsants Market, Segmentation By Drug Generation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 38: South Korea, Anticonvulsants Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 39: Western Europe, Anticonvulsants Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 40: Western Europe, Anticonvulsants Market, Segmentation By Drug Generation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 41: Western Europe, Anticonvulsants Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 42: UK, Anticonvulsants Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 43: UK, Anticonvulsants Market, Segmentation By Drug Generation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 44: UK, Anticonvulsants Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 45: Germany, Anticonvulsants Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 46: Germany, Anticonvulsants Market, Segmentation By Drug Generation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 47: Germany, Anticonvulsants Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 48: France, Anticonvulsants Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 49: France, Anticonvulsants Market, Segmentation By Drug Generation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 50: France, Anticonvulsants Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 51: Italy, Anticonvulsants Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 52: Italy, Anticonvulsants Market, Segmentation By Drug Generation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 53: Italy, Anticonvulsants Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 54: Spain, Anticonvulsants Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 55: Spain, Anticonvulsants Market, Segmentation By Drug Generation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 56: Spain, Anticonvulsants Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 57: Eastern Europe, Anticonvulsants Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 58: Eastern Europe, Anticonvulsants Market, Segmentation By Drug Generation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 59: Eastern Europe, Anticonvulsants Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 60: Russia, Anticonvulsants Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 61: Russia, Anticonvulsants Market, Segmentation By Drug Generation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 62: Russia, Anticonvulsants Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 63: North America, Anticonvulsants Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 64: North America, Anticonvulsants Market, Segmentation By Drug Generation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 65: North America, Anticonvulsants Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 66: USA, Anticonvulsants Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 67: USA, Anticonvulsants Market, Segmentation By Drug Generation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 68: USA, Anticonvulsants Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 69: Canada, Anticonvulsants Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 70: Canada, Anticonvulsants Market, Segmentation By Drug Generation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 71: Canada, Anticonvulsants Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 72: South America, Anticonvulsants Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 73: South America, Anticonvulsants Market, Segmentation By Drug Generation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 74: South America, Anticonvulsants Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 75: Brazil, Anticonvulsants Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 76: Brazil, Anticonvulsants Market, Segmentation By Drug Generation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 77: Brazil, Anticonvulsants Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 78: Middle East, Anticonvulsants Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 79: Middle East, Anticonvulsants Market, Segmentation By Drug Generation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 80: Middle East, Anticonvulsants Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 81: Africa, Anticonvulsants Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 82: Africa, Anticonvulsants Market, Segmentation By Drug Generation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 83: Africa, Anticonvulsants Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 84: Eisai Co Ltd. Financial Performance
  • Figure 85: GlaxoSmithKline plc Financial Performance
  • Figure 86: Pfizer Inc. Financial Performance
  • Figure 87: Johnson & Johnson Services Inc . Financial Performance
  • Figure 88: Novartis AG Financial Performance

Global Complete Nutrition Products Market Landscape: Trends and Market Share to 2029

Read More About Global Complete Nutrition Products Market Landscape: Trends and Market Share to 2029

Competitive and Market Trend Analysis of Conjugate Vaccine Industry Through 2029

Read More About Competitive and Market Trend Analysis of Conjugate Vaccine Industry Through 2029

Industry Trends Show Cosmeceuticals Market Set to Expand at 8.8% CAGR Until 2029

Read More About Industry Trends Show Cosmeceuticals Market Set to Expand at 8.8% CAGR Until 2029

Strategic Report on Cosmetic Ingredients Market: Growth Opportunities and Emerging Challenges

Read More About Strategic Report on Cosmetic Ingredients Market: Growth Opportunities and Emerging Challenges

A 2025 analysis offering size estimates, growth trends and technological innovations in the live cell imaging microscopes market.

Read More About A 2025 analysis offering size estimates, growth trends and technological innovations in the live cell imaging microscopes market.

A 2025 market overview covering growth forecasts, treatment landscape, and key stakeholders in the isovaleric acidemia treatment market.

Read More About A 2025 market overview covering growth forecasts, treatment landscape, and key stakeholders in the isovaleric acidemia treatment market.

A dynamic 2025 report outlining growth drivers, pipeline innovations, and key markets in liver cancer therapeutics.

Read More About A dynamic 2025 report outlining growth drivers, pipeline innovations, and key markets in liver cancer therapeutics.

A 2025 analysis tracking API pricing, competitive landscape, and growth strategies in the losartan potassium active pharmaceutical ingredient market.

Read More About A 2025 analysis tracking API pricing, competitive landscape, and growth strategies in the losartan potassium active pharmaceutical ingredient market.

Anticonvulsants Global Market Report 2025 – By Type (Pyrimidinediones, Benzodiazepines, Fructose Derivatives, Aromatic Allylic Alcohols, Valproylamides, Carboxamides, Bromides, Other Types), By Drug Generation (First Gen...

View Report

Antiepileptic Drugs Global Market Report 2025 – By Drug (First Generation, Second Generation, Third Generation), By Form (Dry, Liquid), By Route Of Administration (Oral, Intravenous, Other Routes Of Administration), By D...

View Report

Ovulation Inducing Drugs Global Market Report 2025 – By Drug Class (Hormones, Therapeutics Drugs), By Route Of Administration (Oral, Parenteral, Other Routes Of Administration), By End-User (Hospital, Homecare, Specialty...

View Report

Antipsychotic Drugs Global Market Report 2025 – By Therapeutic Class (First Generation, Second Generation, Third Generation), By Disease (Schizophrenia, Bipolar Disorder, Unipolar Depression, Dementia, Other Diseases), B...

View Report

Antiparasitic Drugs Global Market Report 2025 – By Product Type (Anthelmintics, Antiprotozoals, Ectoparasiticide, Other Products), By Treatment (Avermectins, Bezimidazoles, Pyrimidines, Organophosphates, Imidazolesthiazo...

View Report

Epilepsy Drugs Global Market Report 2025 – By Seizure Type (Focal Seizures, Generalized Seizures, Non-Epileptic Seizures), By Generation Type (First Generation Anti-Epileptics, Second Generation Anti-Epileptics, Third Ge...

View Report

Antiemetics And Antinauseants Global Market Report 2025 – By Drug (Dopamine antagonists, NK1 receptor antagonist, Antihistamines (H1 histamine receptor antagonists), Cannabinoids, Benzodiazepines, Anticholinergics, Stero...

View Report

Antidepressants Global Market Report 2025 – By Product (Selective Serotonin Reuptake Inhibitor (SSRI), Serotonin-norepinephrine Reuptake Inhibitor (SNRI), Tricyclic Antidepressant (TCA), Monoamine Oxidase Inhibitor (MAOI...

View Report

Frequently Asked Questions

Anticonvulsants, also called anti-seizure medication and antiepileptics, refer to a type of drug or medication used to prevent and treat seizures or convulsions by controlling abnormal electrical activity in the brain. This medication is used to treat conditions such as nerve pain and restless leg syndrome. For further insights on this market, request a sample here

The market major growth driver - The Surge In Epilepsy Cases Drives Growth In The Anticonvulsants Market. For further insights on this market, request a sample here

The anticonvulsants market size has grown steadily in recent years. It will grow from $18.85 billion in 2024 to $19.25 billion in 2025 at a compound annual growth rate (CAGR) of 2.1%. The growth in the historic period can be attributed to the rising prevalence of epilepsy, advancements in diagnostic capabilities, expanding indications, focus on personalized medicine, and increased awareness and education The anticonvulsants market size is expected to see steady growth in the next few years. It will grow to " $22.29 billion in 2029 at a compound annual growth rate (CAGR) of 3.7%. The growth in the forecast period can be attributed to continuing increase in epilepsy cases, expanding applications in neuropsychiatry, development of new anticonvulsant agents, increasing emphasis on mental health, global health initiatives. Major trends in the forecast period include pediatric applications and formulations, shift towards extended-release formulations, growing adoption of generic versions, integration with digital health solutions, and research on neuroprotective effects. For further insights on this market, request a sample here

The anticonvulsants market covered in this report is segmented –
1) By Type: Pyrimidinediones, Benzodiazepines, Fructose Derivatives, Aromatic Allylic Alcohols, Valproylamides, Carboxamides, Bromides, Other Types
2) By Drug Generation: First Generation, Second Generation, Third Generation
3) By Dosage: Capsule, Tablet, Cream, Liquid, Rectal Gel, Other Dosages
4) By Application: Migraine, Epilepsy, Neuropathic Pain, Anxiety, Fibromyalgia, Bipolar Disorder, Borderline Personality Disorder
5) By End-User: Hospitals, Clinics, Other End-Users Subsegments:
1) By Pyrimidinediones: Stiripentol
2) By Benzodiazepines: Clonazepam, Diazepam, Lorazepam
3) By Fructose Derivatives: S-licarbazepine, Other Fructose Derivatives
4) By Aromatic Allylic Alcohols: Felbamate, Other Aromatic Allylic Alcohols
5) By Valproylamides: Valproic Acid, Divalproex Sodium
6) By Carboxamides: Lamotrigine, Other Carboxamides
7) By Bromides: Potassium Bromide, Sodium Bromide
8) By Other Types: Topiramate, Zonisamide, Ethosuximide For further insights on this market, request a sample here

North America was the largest region in the anticonvulsants market in 2024.Asia-Pacific is expected to be the fastest-growing region in the global anticonvulsants market report during the forecast period. The regions covered in the anticonvulsants market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa For further insights on this market, request a sample here.

Major companies operating in the anticonvulsants market include Eisai Co Ltd., GlaxoSmithKline plc, Pfizer Inc., Johnson & Johnson Services Inc ., Novartis AG, Jazz Pharmaceuticals Inc., UCB SA, Teva Pharmaceutical Industries Ltd., Sunovion Pharmaceuticals Inc., Sanofi SA, Zydus Lifesciences Ltd., Lupin Limited, Ratiopharm Group, Kannalife Inc., AbbVie Inc., Sun Pharmaceutical Industries Ltd., Cipla Limited, Mylan N.V., Aurobindo Pharma Limited, Dr. Reddy's Laboratories Ltd., Torrent Pharmaceuticals Ltd., Hikma Pharmaceuticals plc, AstraZeneca plc, Glenmark Pharmaceuticals Limited, Laurus Labs Limited, Biocon Limited, Recordati S.p.A., Neurocrine Biosciences Inc. . For further insights on this market, request a sample here.

Major trends in this market include Innovative Product Development Drives Advancements In The Anticonvulsants Market. For further insights on this market, request a sample here.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us
Global Anticonvulsants Market Report 2025

Wait, we have a special offer for you! ✋

Get your exclusive 20% discount only on the Global Market Reports now using the code ONLINE20*

YES, get the discount! No, I'd pay the full price

*Copy paste the discount code in the cart

Back to top WhatsApp icon